Intra Cellular Therapies shares owned by Neuberger Berman Group
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Neuberger Berman Group
from 13F filings
Historical chart of Neuberger Berman Group investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Neuberger Berman Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $42M | 319k | 131.92 |
| 2024-12-31 | $7.4M | 88k | 83.52 |
| 2024-09-30 | $6.4M | 87k | 73.17 |
| 2024-06-30 | $6.6M | 96k | 68.49 |
| 2024-03-31 | $5.7M | 82k | 69.20 |
| 2023-12-31 | $4.0M | 56k | 71.62 |
| 2023-09-30 | $325k | 6.2k | 52.09 |
| 2023-06-30 | $371k | 5.9k | 63.32 |
| 2023-03-31 | $293k | 5.4k | 54.15 |
| 2022-12-31 | $225k | 4.3k | 52.92 |
| 2015-12-31 | $403k | 7.5k | 53.73 |
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies